- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05079919
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
February 5, 2026 updated by: Ionis Pharmaceuticals, Inc.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ISIS 678354 Administered Subcutaneously to Patients With Severe Hypertriglyceridemia
The purpose of the study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a multi-center, randomized, double-blind, placebo-controlled study in 617 participants.
Participants will be randomized to receive olezarsen or placebo in a 53-week treatment period.
The length of participation in the study will be approximately 78 weeks, which includes an up to 12-week screening period, a 53-week treatment period, and a 13-week post-treatment evaluation period or transition to open-label extension (OLE) study with up to 1-year treatment.
Study Type
Interventional
Enrollment (Actual)
617
Phase
- Phase 3
Expanded Access
Approved for sale to the public.
See expanded access record.
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Adelaide, Australia, 5000
- Royal Adelaide Hospital
-
-
New South Wales
-
Camperdown, New South Wales, Australia, 2050
- Royal Prince Alfred Hospital
-
Saint Leonards, New South Wales, Australia, 2065
- Royal North Shoe Hospital
-
-
Queensland
-
Woolloongabba, Queensland, Australia, 4102
- Dr. Heart Pty Ltd at Cholesterol Care Australia
-
-
Victoria
-
Clayton S., Victoria, Australia, 3168
- Monash Medical Centre
-
Melbourne, Victoria, Australia, 3004
- The Alfred Hospital
-
-
-
-
-
Blagoevgrad, Bulgaria, 2700
- MHAT Blagoevgrad AD
-
Burgas, Bulgaria, 8008
- Medical Center Doctor Staykov EOOD
-
Dimitrovgrad, Bulgaria, 6400
- Medical Center Diamedical 2013 OOD
-
Gabrovo, Bulgaria, 5300
- MHAT "Dr. Tota Venkova" AD
-
Montana, Bulgaria, 3400
- Medical Center "Hera" EOOD
-
Plovdiv, Bulgaria, 4000
- SHAT "Special Medic" Ltd
-
Rousse, Bulgaria, 7000
- Medical Center Rusemed EOOD
-
Sliven, Bulgaria, 8800
- DCC 1 Sliven
-
Sliven, Bulgaria, 8800
- Gabriela Zhelyazkova
-
Smolyan, Bulgaria, 4700
- Medical center Smolyan clinical research OOD
-
Sofia, Bulgaria, 1797
- UMHAT Sofiamed OOD
-
Sofia, Bulgaria, 1606
- Medical Center Endomedical EOOD
-
Sofia, Bulgaria, 1680
- Medical Centar "KALIMAT"
-
Sofia, Bulgaria, 1700
- MC Doctor Kalchev OOD
-
Stara Zagora, Bulgaria, 6000
- New Rehabilitation Center
-
Stara Zagora, Bulgaria, 6000
- UMHAT Prof. Dr. Stoyan Kirkovich AD, Clinic of Cardiology
-
Veliko Tarnovo, Bulgaria, 5006
- Medical Centre Nevromedics EOOD
-
-
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 2C7
- ARC Biosystems
-
-
Ontario
-
Toronto, Ontario, Canada, M3J 0K2
- Canadian Phase Onward Inc
-
-
Quebec
-
Chicoutimi, Quebec, Canada, G7H 7K9
- Ecogene-21
-
Montreal, Quebec, Canada, H2W 1R7
- Institut de recherches cliniques de Montréal (IRCM)
-
Québec, Quebec, Canada, G1V 4W2
- Clinique des Maladies Lipidiques de Quebec Inc.
-
-
-
-
-
Brandýs nad Labem, Czechia, 250 01
- Medicus Services s.r.o.
-
Hradec Králové, Czechia, 500 02
- EDUMED s.r.o.
-
Hradec Králové, Czechia, 500-05
- Fakultni nemocnice Hradec Kralove
-
Náchod, Czechia, 547 01
- EDUMED s.r.o.
-
Ostrava, Czechia, 70852
- Fakultni Nemocnice Ostrava
-
Prague, Czechia, 128 08
- Vseobecna Fakultni Nemocnice
-
Prague, Czechia, 15800
- Lekarna Poliklinika Hurka
-
Uherské Hradiště, Czechia, 686 01
- Interni ambulance
-
-
-
-
-
Aalborg, Denmark, 9000
- Aalborg University Hospital
-
Aarhus, Denmark, 8200
- Aarhus University Hospital
-
Esbjerg, Denmark, 6700
- Esbjerg Hospital
-
Frederiksberg, Denmark, 2000
- Bispebjerg Hospital
-
Herlev, Denmark, 2730
- Herlev Hospital
-
Herning, Denmark, 7400
- Godstrup Regional Hospital
-
Viborg, Denmark, 8800
- Regionshospitalet Viborg
-
-
-
-
-
Turku, Finland, 20520
- Turku University Hospital
-
Ylitornio, Finland, 95600
- Ylitornio Health Care Center
-
-
-
-
-
Bron, France, 69677
- Hôpital Louis Pradel
-
Dijon, France, 21079
- Chu Dijon Bourgogne
-
Marseille, France, 13005
- Hôpital de la Conception
-
Montpellier, France, 34295
- CHU Montpellier - Hôpital Lapeyronie
-
Paris, France, 75013
- Hopital Pitie Salpetriere APHP
-
Saint-Herblain, France, 44093
- CHU Nantes - Hopital Nord Laënnec
-
-
-
-
-
Berlin, Germany, 13353
- Stoffwechselcentrum Charite Campus Virchow
-
Cologne, Germany, 50937
- Uniklinik Koln
-
Dresden, Germany, 1307
- Universitaetsklinikum Carl Gustav Carus an der TU Dresden
-
Hamburg, Germany, 20253
- Klinische Forschung Hamburg GmbH
-
Hanover, Germany, 30159
- Klinische Forschung Hannover-Mitte GmbH
-
Heidelberg, Germany, 69115
- St. Josefskrankenhaus,
-
Markkleeberg, Germany, 04416
- Praxis Dr. med. Taggeselle
-
Papenburg, Germany, 26871
- Kardiologische Praxis in Papenburg
-
Witten, Germany, 58455
- Evangelisches Krankenhaus Witten
-
-
-
-
-
Borsod, Hungary, 3860
- CRU Hungary Kft
-
Budapest, Hungary, H-1062
- Észak-Pesti Centrumkórház - Honvédkórház; II. Belgyógyászati Osztály
-
Budapest, Hungary, H-1085
- Semmelweis Egyetem Kardiológiai Rehabilitacio
-
Debrecen, Hungary, 4025
- Belinus Bt
-
Debrecen, Hungary, 4032
- Debreceni Egyetem Klinikai Kozpont Belgyogyaszat A epulet
-
Miskolc, Hungary, H-3530
- IPR Hungary Kft.
-
Nyíregyháza, Hungary, 4405
- Borbanya Praxis Eü KFT
-
Székesfehérvár, Hungary, 8000
- Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
-
Veszprém, Hungary, 8230
- DRC Gyogyszervizsgalo Kozpont Kft
-
-
Heves County
-
Hatvan, Heves County, Hungary, 3000
- BKS Research Kft
-
-
Szabolcs-Szatmár-Bereg
-
Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary, 4400
- Medifarma 98 Kft
-
-
-
-
-
Beersheba, Israel, 8410101
- Soroka Medical Center
-
Haifa, Israel, 3436212
- Lady Davis Carmel Medical Center
-
Haifa, Israel, 3339416
- Bnai Zion Medical Center
-
Jerusalem, Israel, 9103102
- Shaare Zedek Medical Center
-
Jerusalem, Israel, 91120
- Hadassah Hebrew University Ein Kerm MC
-
Petah Tikva, Israel, 4941492
- Rabin Medical Center
-
Rehovot, Israel, 7661041
- Kaplan Medical Center
-
Tel Aviv, Israel, 6423909
- Sourasky Medical Center
-
Tel Litwinsky, Israel, 5265601
- Sheba Medical Center
-
-
-
-
-
Bologna, Italy, 40138
- IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di SantOrsola
-
Milan, Italy, 20162
- Asst Grande Ospedale Metropolitano Niguarda
-
Milan, Italy, 20092
- Ospdale E. Bassini
-
Napoli, Italy, 80131
- Azienda Ospedaliera Universitaria Federico II
-
Palermo, Italy, 90127
- A.O. Policlinico Universitario P. Giaccone
-
Roma, Italy, 00168
- Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
-
Roma, Italy, 00161
- Policlinico Umberto
-
-
-
-
-
Amsterdam, Netherlands, 1105 AZ
- Academic Medical Center - Department of Vascular Medicine
-
Arnhem, Netherlands, 6815 AD
- Rijnstate Arnhem
-
Dordrecht, Netherlands, 3318 AT
- Albert Schweitzer Ziekenhuis
-
Ede, Netherlands, 6716 RP
- Ziekenhuis Gelderse Vallei
-
Nijmegen, Netherlands, 6525 GA
- Radboud UMC
-
Rotterdam, Netherlands, 3015 GD
- Erasmus MC
-
Utrecht, Netherlands, 3584 CX
- Universitair Medisch Centrum Utrecht
-
-
-
-
-
Christchurch, New Zealand, 8011
- New Zealand Clinical Research
-
Newtown, New Zealand, 6021
- Wellington Regional Hospital
-
-
Auckland
-
Grafton, Auckland, New Zealand, 1010
- Auckland City Hospital
-
-
-
-
-
Oslo, Norway, 0586
- Lipid Clinic
-
-
-
-
-
Katowice, Poland, 40-772
- Salvia
-
Poznan, Poland, 61-655
- Praktyka Lekarska Ewa Krzyzagorska
-
Skierniewice, Poland, 96-100
- ClinMedica Research Sp.z o.o.
-
Tarnów, Poland, 33-100
- Osrodek Badan Klinicznych Metabolica
-
Wroclaw, Poland, 50-088
- Futuremeds sp. z o.o
-
Łódz, Poland, 93-338
- Instytut Centrum Zdrowia Matki Polki Klinika
-
-
-
-
-
Aveiro, Portugal, 3814-501
- Centro Hospitalar do Baixo Vouga Hospital Infante D. Pedro
-
Coimbra, Portugal, 3004-561
- Centro Hospitalar e Universitário de Coimbra, EPE
-
Lisbon, Portugal, 1349-019
- Hospital Egas Moniz - Centro Hospitalar de Lisboa Ocidental
-
Porto, Portugal, 4200-319
- Centro Hospitalar Universitário de São João Consultas Externas de Endocrinologia K13
-
Vila Nova de Gaia, Portugal, 4434-502
- Centro Hospitalar
-
-
-
-
-
Bratislava, Slovakia, 851 01
- Medispektrum s.r.o., diabetologicka a metabolicka ambulancia
-
Brezno, Slovakia, 97701
- Nemocnica s poliklinikou Brezno
-
Košice, Slovakia, 040 01
- Human-Care s.r.o.
-
Košice, Slovakia, 040 22
- Cardio D&R
-
Košice, Slovakia, 040 11
- Vychodoslovensky Ustav srdcovych a cievnych chorob a.s.
-
Svidník, Slovakia, 089 01
- Nemocnica arm. generala L. Svobodu Svidnik,
-
-
-
-
-
Cape Town, South Africa, 7925
- University of Cape town - Lipid Factory
-
Chatsworth, South Africa, 4092
- Chatsmed Garden Hospital
-
-
Free State
-
Bloemfontein, Free State, South Africa, 9301
- Iatros International
-
-
Gauteng
-
Centurion, Gauteng, South Africa, 157
- Unitas Hospital
-
-
Western Cape
-
Cape Town, Western Cape, South Africa, 7130
- Dr Jan Engelbrecht and Ass. Inc
-
Parow, Western Cape, South Africa, 7500
- TREAD Research - Department of Cardiology
-
-
-
-
-
A Coruña, Spain, 15001
- Hospital Abente y Lago
-
Barcelona, Spain, 8907
- Hospital Universitari de Bellvitge
-
Barcelona, Spain, 08041
- Hospital de la Santa Creu i de Sant Pau
-
Barcelona, Spain, 8063
- Hospital Clinic Barcelona
-
Barcelona, Spain, 8208
- Institut d'Investigació i Innovació Parc Taulí (I3PT) Departament Medicina Universitat
-
Córdoba, Spain, 14004
- Hospital Universitario Reina Sofia
-
Madrid, Spain, 28027
- Clinica Universidad de Navarra
-
Madrid, Spain, 28041
- Hospital Universitario
-
Seville, Spain, 41013
- Hospital Virgen del Rocio Edificio Centro de Diagnostico y Tratamiento (CDT)
-
Tarragona, Spain, 43204
- Hospital Universitari Sant Joan de Reus.
-
-
-
-
-
Stockholm, Sweden, 14186
- Karolinska University Hospital Huddinge
-
-
Västra Götaland County
-
Gothenburg, Västra Götaland County, Sweden, 413 45
- Sahlgrenska, University Hospital
-
-
-
-
-
Ankara, Turkey (Türkiye), 06230
- Hacettepe University Medical Faculty
-
Izmir, Turkey (Türkiye), 35100
- Ege University School of Medicine, Department of Cardiology
-
Kocaeli, Turkey (Türkiye), 41380
- Kocaeli University Faculty of Medicine
-
Konya, Turkey (Türkiye), 42280
- Necmettin Erbakan University Meram Medical Faculty
-
-
-
-
-
Blackpool, United Kingdom, FY4 3AD
- Waterloo Medical Centre
-
Cornwell, United Kingdom, TR27 5DT
- Mounts Bay Medical Hub
-
Glasgow, United Kingdom, G51 4TY
- Panthera
-
Hull, United Kingdom, HU3 2JZ
- Hull Royal Infirmary
-
London, United Kingdom, EN3 4GS
- Panthera
-
Manchester, United Kingdom, M13 9WL
- Manchester University NHS Foundation Trust (MFT)
-
Preston, United Kingdom, PR2 9QB
- Panthera
-
Sheffield, United Kingdom, S94EU
- Primary Care Sheffield
-
-
Cornwall
-
Liskeard, Cornwall, United Kingdom, PL14 3XA
- Oak Tree Surgery and Pensilva Health Centre
-
Newquay, Cornwall, United Kingdom, TR7 1RU
- Newquay Health Centre
-
-
Dorset
-
Poole, Dorset, United Kingdom, BH16 5PW
- Upton Surgery
-
-
England
-
Rochdale, England, United Kingdom, OL11 4AU
- Panthera Biopartners
-
Sheffield, England, United Kingdom, S2 5FX
- Panthera Biopartners
-
-
Huddersfield
-
Lindley, Huddersfield, United Kingdom, HD3 3EA
- Huddersfield Royal Infirmary
-
-
Northamptonshire
-
Corby, Northamptonshire, United Kingdom, NN172UR
- Lakeside Healthcare at Corby
-
-
West Bromwich
-
Lyne, West Bromwich, United Kingdom, B71 4HJ
- Sandwell General Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35216
- Accel Research Sites Network
-
-
Arizona
-
Scottsdale, Arizona, United States, 85259
- Mayo Clinic
-
-
California
-
Chula Vista, California, United States, 91911
- Velocity Clinical Research
-
Huntington Beach, California, United States, 92648
- Diabetes/Lipid Management & Research Center
-
La Jolla, California, United States, 92037
- University of California, San Diego (UCSD)
-
Los Angeles, California, United States, 90057
- LA Universal Research Center, Inc.
-
Tarzana, California, United States, 91356
- America Clinical Trials
-
-
Florida
-
Boca Raton, Florida, United States, 33434
- Excel Medical Clinical Trials, LLC
-
Chiefland, Florida, United States, 32626
- Southeast Clinical Research LLC
-
Jacksonville, Florida, United States, 32205
- Westside Center For Clinical Research
-
Miami, Florida, United States, 33126
- Finlay Medical Research
-
Miramar, Florida, United States, 33027
- Innovia Research Center, INC
-
Ocala, Florida, United States, 34471
- Ocala Cardiovascular Research
-
St. Petersburg, Florida, United States, 33709
- IMA Clinical Research
-
Tampa, Florida, United States, 33614
- VICIS Clinical Research
-
Trinity, Florida, United States, 34655
- Bayside Clinical Research
-
-
Georgia
-
Columbus, Georgia, United States, 31904
- IACT Health
-
-
Illinois
-
Chicago, Illinois, United States, 60602
- IMA Clinical Research Chicago
-
Oak Brook, Illinois, United States, 60523
- Affinity Health
-
-
Iowa
-
Council Bluffs, Iowa, United States, 51501
- West Broadway Clinic
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- Kansas University Medical Center
-
-
Louisiana
-
Monroe, Louisiana, United States, 71201
- Clinical Trials of America, LLC
-
-
Maryland
-
Towson, Maryland, United States, 21204
- Continental Clinical Solutions
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Hospital and Health Systems/ Dept. of Pharmacy-Research Pharmacy
-
Flint, Michigan, United States, 48504
- Aa Mrc, Llc
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
St Louis, Missouri, United States, 63117
- IMA Clinical Research
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68506
- Bryan Medical Center Clinical Research
-
-
Nevada
-
Las Vegas, Nevada, United States, 89148
- Palm Research Center, Inc.
-
-
New Jersey
-
Union City, New Jersey, United States, 07087
- Hudson County Clinical Trials Research Center
-
-
New York
-
Brooklyn, New York, United States, 11235
- Modern Medicine
-
Great Neck, New York, United States, 11021
- Northwell Health
-
Middletown, New York, United States, 10941
- Circuit Clinical (Crystal Run Healthcare)
-
New York, New York, United States, 10032
- Columbia University
-
New York, New York, United States, 10016
- NYU Langone
-
Niagara Falls, New York, United States, 14304
- Circuit Clinical
-
Syosset, New York, United States, 11791
- Modern Medical
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28204
- Novant Health Cancer Institute Elizabeth Investigational Drug Services
-
Greensboro, North Carolina, United States, 27401
- Cone Medical Center
-
Mount Airy, North Carolina, United States, 27030
- Clinical Trials of America, LLC
-
Salem, North Carolina, United States, 27157
- Wake Forest University Health Sciences
-
-
Ohio
-
Columbus, Ohio, United States, 43213
- Aventiv Research
-
Munroe Falls, Ohio, United States, 44262
- Summit Research Group, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73102
- Hightower Clinical Trial Services
-
-
Oregon
-
Medford, Oregon, United States, 97504
- Velocity Clinical Research
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- The Miriam Hospital
-
-
South Dakota
-
Rapid City, South Dakota, United States, 57702
- Health Concepts
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Chattanooga Research & Medicine, PLLC
-
-
Texas
-
Cedar Park, Texas, United States, 78613
- Velocity Clinical Research
-
Dallas, Texas, United States, 75390
- University of Texas Southwestern
-
Houston, Texas, United States, 77030
- Baylor College of Medicine
-
Sugar Land, Texas, United States, 77478
- Medicus Alliance Clinical Research
-
-
Utah
-
West Jordan, Utah, United States, 84088
- Velocity Clinical
-
-
Virginia
-
Manassas, Virginia, United States, 20110
- Manassas Clinical Research Center
-
Norfolk, Virginia, United States, 23510
- York Clinical Research LLC
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26506
- West Virginia University Heart and Vascular Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Key Inclusion Criteria:
- Fasting TG ≥ 500 mg/dL (5.65 mmol/L) at Screening and Qualification
- Patients must be on lipid-lowering therapy that should adhere to standard of care (SOC) per local guidelines. Lipid-lowering medications should be optimized and stabilized for at least 4 weeks prior to Screening to minimize changes in these medications during the study.
Key Exclusion Criteria:
- Hemoglobin A1c (HbA1c) ≥ 9.5% at Screening
- Alanine aminotransferase or aspartate aminotransferase > 3.0 × upper limit of normal
- Total bilirubin > upper limit of normal unless due to Gilbert's syndrome
- Estimated GFR < 30 mL/min/1.73 m^2
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Olezarsen
Olezarsen will be administered once every 4 weeks by subcutaneous (SC) injection from Week 1 through Week 49.
|
Olezarsen will be administered by SC injection.
Other Names:
|
|
Placebo Comparator: Placebo
Olezarsen-matching placebo will be administered once every 4 weeks by SC injection from Week 1 through Week 49.
|
Olezarsen-matching placebo will be administered by SC injection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percent Change from Baseline in Fasting TG Compared to Placebo
Time Frame: Baseline and Month 6
|
Baseline and Month 6
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adjudicated Acute Pancreatitis Event Rate During the Treatment Period Compared to Placebo
Time Frame: Week 1 through Week 53
|
Week 1 through Week 53
|
|
Percent Change from Baseline in Fasting TG Compared to Placebo
Time Frame: Baseline and Month 12
|
Baseline and Month 12
|
|
Percent Change from Baseline in Fasting Apolipoprotein C-III (ApoC-III), Remnant Cholesterol and Fasting Non-High-Density Lipoprotein-Cholesterol (Non-HDL-C) Compared to Placebo
Time Frame: Baseline, Month 6 and 12
|
Baseline, Month 6 and 12
|
|
Proportion of Patients Who Achieve Fasting TG <500 mg/dL (5.65 mmol/L) Compared to Placebo
Time Frame: Month 12
|
Month 12
|
|
Proportion of Participants Who Achieve Fasting TG < 880 mg/dL (10 mmol/L) Compared to Placebo in the Subgroup of Participants with Baseline TG ≥ 880 mg/dL
Time Frame: Month 12
|
Month 12
|
|
Absolute Change in Hepatic Fat Fraction (HFF) Between Olezarsen Treatment Group and Pooled Placebo
Time Frame: Baseline through Month 12
|
Baseline through Month 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Marston NA, Bergmark BA, Alexander VJ, Karwatowska-Prokopczuk E, Kang YM, Moura FA, Prohaska TA, Zimerman A, Zhang S, Murphy SA, Tsimikas S, Giugliano RP, Sabatine MS. Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia. Am Heart J. 2025 Aug;286:125-135. doi: 10.1016/j.ahj.2025.03.003. Epub 2025 Mar 9.
- Marston NA, Bergmark BA, Alexander VJ, Prohaska TA, Kang YM, Moura FA, Zimerman A, Waldman E, Weinland J, Murphy SA, Goodrich EL, Zhang S, Xia S, Li D, Goldberg AC, Goudev A, Badimon L, Kiss RG, Vrablik M, Gaudet D, Moulin P, Stroes ESG, Banach M, Cohen H, Blom D, Charng MJ, Nordestgaard BG, Nicholls SJ, Tsimikas S, Giugliano RP, Sabatine MS; CORE-TIMI 72a and CORE2-TIMI 72b Investigators. Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk. N Engl J Med. 2026 Jan 29;394(5):429-441. doi: 10.1056/NEJMoa2512761. Epub 2025 Nov 8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 25, 2021
Primary Completion (Actual)
October 22, 2024
Study Completion (Actual)
July 8, 2025
Study Registration Dates
First Submitted
October 4, 2021
First Submitted That Met QC Criteria
October 4, 2021
First Posted (Actual)
October 15, 2021
Study Record Updates
Last Update Posted (Actual)
February 10, 2026
Last Update Submitted That Met QC Criteria
February 5, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ISIS 678354-CS5
- 2021-002192-19 (EudraCT Number)
- 2024-510696-38-00 (Ctis)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Ionis may share anonymized individual participant data, aggregated clinical data, and other types of data that support the results in this study.
Data requests from qualified researchers will be considered once all three of the following criteria are met: (1) 12 months from marketing approval of the study drug in both the United States and European Union; (2) 18 months from conclusion of the study; and (3) 6 months from publication of study article.
Access would be via a secure environment and is contingent upon approval of a research proposal and entry into an appropriate data use agreement.
Requests to access data can be submitted via the website https://vivli.org/ourmember/ionis/.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Hypertriglyceridemia
-
Ionis Pharmaceuticals, Inc.RecruitingHypertriglyceridemia | Severe HypertriglyceridemiaUnited States
-
Eli Lilly and CompanyRecruitingSevere HypertriglyceridemiaUnited States, China, Japan, Canada
-
Arrowhead PharmaceuticalsActive, not recruitingSevere HypertriglyceridemiaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Hungary, Italy, Poland, Romania, Slovakia, Spain, United Kingdom
-
89bio, Inc.Active, not recruitingSevere HypertriglyceridemiaUnited States, Puerto Rico, Hungary, Poland, Argentina, Austria, Belgium, Bulgaria, Canada, Chile, Czechia, France, Georgia, Germany, India, Italy, Latvia, Mexico, Spain, United Kingdom
-
Sancilio and Company, Inc.WithdrawnSevere Hypertriglyceridemia
-
Arrowhead PharmaceuticalsCompletedSevere HypertriglyceridemiaUnited States, Australia, Canada, Germany, Hungary, Netherlands, New Zealand, Poland
-
AstraZenecaCompletedSevere HypertriglyceridemiaUnited States, Hungary, India, Russian Federation, Denmark, Ukraine, Netherlands
-
AstraZenecaRadiant ResearchCompletedSevere HypertriglyceridemiaUnited States
-
Trygg Pharma, Inc.UnknownSevere HypertriglyceridemiaUnited States
-
Zhejiang Doer Biologics Co., Ltd.CompletedSevere HypertriglyceridemiaChina
Clinical Trials on Olezarsen
-
Ionis Pharmaceuticals, Inc.Approved for marketingFamilial Chylomicronemia SyndromeUnited States
-
Ionis Pharmaceuticals, Inc.Completed
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeUnited States, Canada, Sweden
-
Ionis Pharmaceuticals, Inc.Active, not recruitingSevere HypertriglyceridemiaFinland, United States, Netherlands, Spain, Israel, Belgium, United Kingdom, India, Hungary, Taiwan, Greece, France, Denmark, Australia, Italy, Canada, Czechia, Argentina, Poland, South Africa, Portugal, Sweden, Germany, Bulgaria, Lithu... and more
-
Ionis Pharmaceuticals, Inc.Active, not recruitingFamilial Chylomicronemia SyndromeSpain, United Kingdom, France, Canada, United States, Italy, Netherlands, Norway, Portugal, Slovakia, Sweden
-
Ionis Pharmaceuticals, Inc.CompletedHypertriglyceridemia | Atherosclerotic Cardiovascular Disease | Severe HypertriglyceridemiaUnited States, Canada
-
Ionis Pharmaceuticals, Inc.CompletedSevere HypertriglyceridemiaUnited States, Netherlands, Spain, France, Belgium, Italy, Taiwan, Greece, Slovakia, Bulgaria, Canada, Brazil, Argentina, Malaysia, Portugal, Poland, Mexico, India, Hungary, Czechia, Lithuania, Romania, Sweden
-
Ionis Pharmaceuticals, Inc.CompletedCardiovascular Diseases | Atherosclerosis | HypertriglyceridemiaUnited States, Spain, Italy, Denmark, Hungary, Netherlands, Canada, France, Czechia, Poland, Bulgaria, Portugal, Norway, Slovakia
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompletedFamilial Chylomicronemia SyndromeUnited States, Spain, Italy, United Kingdom, Netherlands, Canada, Sweden, France, Norway, Portugal, Slovakia